Anti-SPARC oligopeptide inhibits laser-induced CNV in mice

Citations of this article
Mendeley users who have this article in their library.


It is known that SPARC gates VEGF-A signal transduction towards KDR, the primary angiogenic VEGF receptor. We sought to determine whether inhibition of SPARC activity using anti-SPARC peptide could inhibit laser-induced CNV by promoting binding of VEGF-A to FLT-1. We created anti-SPARC l-peptide and retro-inverso anti-SPARC d-peptide. Anti-SPARC peptides or PBS were injected intravitreally 1. day before or after laser induction. Intravitreal injection of anti-SPARC l-peptide 1. day before laser induction promotes FLT-1 phosphorylation and inhibited laser-induced CNV and anti-SPARC d-peptide had no effect. Injection 1. day after laser injury did not affect size of laser-induced CNV. Inhibition of SPARC activity could be complementary to existing anti-CNV therapy. © 2009 Elsevier Ltd.




Uehara, H., Luo, L., Simonis, J., Singh, N., Taylor, E. W., & Ambati, B. K. (2010). Anti-SPARC oligopeptide inhibits laser-induced CNV in mice. Vision Research, 50(7), 674–679.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free